+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Safety Market - Global Forecast 2025-2030- Product Image
Drug Safety Market - Global Forecast 2025-2030- Product Image
Sale

Drug Safety Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083125
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug safety market is experiencing rapid transformation, shaped by evolving regulatory requirements, rising stakeholder expectations, and accelerated technology adoption. As pharmaceutical operations grow in complexity, senior decision-makers must navigate a landscape where operational resilience, compliance rigor, and data-driven intelligence are paramount.

Market Snapshot: Drug Safety Market Overview

The Drug Safety Market grew from USD 14.06 billion in 2024 to USD 17.17 billion in 2025. It is expected to continue growing at a CAGR of 21.76%, reaching USD 45.84 billion by 2030. Market momentum is propelled by increased regulatory scrutiny, widespread technology integration, and heightened industry awareness surrounding pharmacovigilance practices. Organizations are recognizing drug safety as a strategic pillar for sustainable growth, optimizing global monitoring, and enhancing cross-border data coordination. The convergence of real-time analytics and proactive signal detection is facilitating swifter responses to emerging patient safety needs.

Scope & Segmentation of the Drug Safety Market

This report delivers a comprehensive analysis, structured across products, services, applications, end users, and key global regions.

  • Product Types: Labeling management, pharmacovigilance systems, regulatory submission management, risk management modules, risk evaluation tools, and risk minimization tools.
  • Service Types: Consulting and advisory services (process optimization and regulatory compliance), implementation and integration (customization services, system integration), outsourcing (case processing, pharmacovigilance), training and technical support for end users.
  • Applications: Adverse event reporting, regulatory compliance management, risk evaluation, safety data management (including data collection and processing), and signal detection.
  • End Users: Biotechnology companies, contract research organizations, hospitals and clinics, pharmaceutical companies, and regulatory authorities.
  • Regions: Americas (including major U.S. states like California, Texas, New York, and others, along with Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (comprising the UK, Germany, France, Russia, Italy, Spain, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea, among others).

The report also evaluates technology adoption and recent developments by leading companies, including IQVIA Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, Oracle Corporation, Veeva Systems Inc., ArisGlobal LLC, and EXL Service Holdings, Inc.

Strategic Insights and Key Takeaways

  • Regulatory agencies worldwide are driving harmonization and adaptive oversight, challenging organizations to implement modular, future-proof pharmacovigilance frameworks.
  • Integration of artificial intelligence and advanced analytics strengthens early detection of safety signals while reducing manual workloads and supporting informed decision-making.
  • Cloud-based collaboration and the use of real-world evidence are enabling cross-jurisdictional data exchange and deeper insights into patient outcomes.
  • Rising influence of patient advocacy and sustained requirements for transparent reporting are positioning stakeholder engagement as a market differentiator.
  • Investment in training and technical support improves user adoption and operational efficiency, minimizing error and system downtime for organizations of varied scale.
  • Collaborative alliances, mergers and acquisitions, and service diversification are shaping provider strategies, aligning with the need for customizable, end-to-end safety solutions.

Tariff Impact: Navigating Policy-Induced Risks

Recent tariff changes in the United States have intensified drug safety market pressures by impacting procurement costs and global supply chain logistics. Manufacturers face higher import levies on critical ingredients and raw materials, prompting strategic shifts in supplier management, quality assurance, and local partnerships. These barriers also delay deployment of pharmacovigilance technologies and elevate scrutiny around cross-border transfer of safety analytics, underscoring the value of resilient, diversified sourcing and robust regional collaboration.

Methodology & Data Sources

This analysis uses a rigorous mixed-method approach, including structured interviews with regulatory, technical, and pharmacovigilance leaders, alongside secondary research from published regulatory documents, corporate reports, and peer-reviewed literature. Systematic triangulation and expert validation ensure analytical integrity and actionable market insights.

SEO Focus: Drug Safety Market for Senior Decision-Makers

This report serves as a critical resource for those overseeing compliance and operational excellence in the drug safety sector. Key benefits include:

  • Identifies emerging risks and strategic shifts in regulatory, technological, and regional arenas.
  • Delivers actionable segmentation to align investments with high-impact product, service, and geographic opportunities.
  • Enables forward-looking decisions by detailing competitive movements and practical frameworks for enhancing market resilience.

Conclusion

The evolving drug safety market demands strategic alignment with regulatory trends, technology advancements, and stakeholder priorities. Organizations equipped with adaptive frameworks, collaborative partnerships, and robust data analytics will build operational resilience and deliver measurable value in safeguarding patient health.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning to predict adverse drug reactions based on electronic health records and real-world data
5.2. Adoption of blockchain technology to secure pharmacovigilance data integrity and improve traceability in adverse event reporting
5.3. Real-time monitoring of patient safety through wearable devices and mobile health applications for early detection of drug side effects
5.4. Incorporation of patient-reported outcomes and social media analytics into signal detection frameworks to enhance post-market safety surveillance
5.5. Implementation of pharmacogenomic profiling and personalized risk assessment tools to tailor drug safety monitoring to individual genetic profiles
5.6. Harmonization of global regulatory requirements and E2B(R3) standards for efficient cross-border safety data exchange and compliance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Safety Market, by Product Type
8.1. Introduction
8.2. Labeling Management
8.3. Pharmacovigilance Systems
8.4. Regulatory Submission Management
8.5. Risk Management Modules
8.5.1. Risk Evaluation Tools
8.5.2. Risk Minimization Tools
9. Drug Safety Market, by Service Type
9.1. Introduction
9.2. Consulting And Advisory
9.2.1. Process Optimization Consulting
9.2.2. Regulatory Compliance Consulting
9.3. Implementation And Integration
9.3.1. Customization Services
9.3.2. System Integration
9.4. Outsourcing
9.4.1. Case Processing Outsourcing
9.4.2. Pharmacovigilance Outsourcing
9.5. Training And Support
9.5.1. End User Training
9.5.2. Technical Support Services
10. Drug Safety Market, by Application
10.1. Introduction
10.2. Adverse Event Reporting
10.3. Regulatory Compliance
10.4. Risk Evaluation
10.5. Safety Data Management
10.5.1. Data Collection
10.5.2. Data Processing
10.6. Signal Detection
11. Drug Safety Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.3. Contract Research Organizations
11.4. Hospitals And Clinics
11.5. Pharmaceutical Companies
11.6. Regulatory Authorities
12. Americas Drug Safety Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Drug Safety Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Drug Safety Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. IQVIA Inc.
15.3.2. Laboratory Corporation of America Holdings
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. ICON plc
15.3.5. Syneos Health, Inc.
15.3.6. Parexel International Corporation
15.3.7. Oracle Corporation
15.3.8. Veeva Systems Inc.
15.3.9. ArisGlobal LLC
15.3.10. EXL Service Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DRUG SAFETY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DRUG SAFETY MARKET: RESEARCHAI
FIGURE 24. DRUG SAFETY MARKET: RESEARCHSTATISTICS
FIGURE 25. DRUG SAFETY MARKET: RESEARCHCONTACTS
FIGURE 26. DRUG SAFETY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG SAFETY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG SAFETY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY LABELING MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY LABELING MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACOVIGILANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACOVIGILANCE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY SUBMISSION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY SUBMISSION MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK EVALUATION TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK EVALUATION TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MINIMIZATION TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MINIMIZATION TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG SAFETY MARKET SIZE, BY PROCESS OPTIMIZATION CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG SAFETY MARKET SIZE, BY PROCESS OPTIMIZATION CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY COMPLIANCE CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY COMPLIANCE CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG SAFETY MARKET SIZE, BY CUSTOMIZATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG SAFETY MARKET SIZE, BY CUSTOMIZATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG SAFETY MARKET SIZE, BY SYSTEM INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG SAFETY MARKET SIZE, BY SYSTEM INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG SAFETY MARKET SIZE, BY CASE PROCESSING OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG SAFETY MARKET SIZE, BY CASE PROCESSING OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACOVIGILANCE OUTSOURCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACOVIGILANCE OUTSOURCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG SAFETY MARKET SIZE, BY TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG SAFETY MARKET SIZE, BY TECHNICAL SUPPORT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG SAFETY MARKET SIZE, BY ADVERSE EVENT REPORTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG SAFETY MARKET SIZE, BY ADVERSE EVENT REPORTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG SAFETY MARKET SIZE, BY RISK EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG SAFETY MARKET SIZE, BY DATA COLLECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG SAFETY MARKET SIZE, BY DATA COLLECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG SAFETY MARKET SIZE, BY DATA PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG SAFETY MARKET SIZE, BY DATA PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG SAFETY MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG SAFETY MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG SAFETY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG SAFETY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG SAFETY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG SAFETY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG SAFETY MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 136. CANADA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 137. CANADA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 140. CANADA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 141. CANADA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 144. CANADA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 145. CANADA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 146. CANADA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 147. CANADA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 150. CANADA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 151. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 166. MEXICO DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 167. MEXICO DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 170. MEXICO DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 258. GERMANY DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 259. GERMANY DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 261. GERMANY DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 266. GERMANY DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 267. GERMANY DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 268. GERMANY DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 269. GERMANY DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 272. GERMANY DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 273. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 278. FRANCE DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 279. FRANCE DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 286. FRANCE DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 287. FRANCE DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 288. FRANCE DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 289. FRANCE DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 292. FRANCE DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 293. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. ITALY DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. ITALY DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. ITALY DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 318. ITALY DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 319. ITALY DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 320. ITALY DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 321. ITALY DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 322. ITALY DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 323. ITALY DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 324. ITALY DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 325. ITALY DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 326. ITALY DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 327. ITALY DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 328. ITALY DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 329. ITALY DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. ITALY DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. ITALY DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 332. ITALY DRUG SAFETY MARKET SIZE, BY SAFETY DATA MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 333. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SPAIN DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. SPAIN DRUG SAFETY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. SPAIN DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2018-2024 (USD MILLION)
TABLE 338. SPAIN DRUG SAFETY MARKET SIZE, BY RISK MANAGEMENT MODULES, 2025-2030 (USD MILLION)
TABLE 339. SPAIN DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 340. SPAIN DRUG SAFETY MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 341. SPAIN DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2018-2024 (USD MILLION)
TABLE 342. SPAIN DRUG SAFETY MARKET SIZE, BY CONSULTING AND ADVISORY, 2025-2030 (USD MILLION)
TABLE 343. SPAIN DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2018-2024 (USD MILLION)
TABLE 344. SPAIN DRUG SAFETY MARKET SIZE, BY IMPLEMENTATION AND INTEGRATION, 2025-2030 (USD MILLION)
TABLE 345. SPAIN DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2018-2024 (USD MILLION)
TABLE 346. SPAIN DRUG SAFETY MARKET SIZE, BY OUTSOURCING, 2025-2030 (USD MILLION)
TABLE 347. SPAIN DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2018-2024 (USD MILLION)
TABLE 348. SPAIN DRUG SAFETY MARKET SIZE, BY TRAINING AND SUPPORT, 2025-2030 (USD MILLION)
TABLE 349. SPAIN DRUG SAFETY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. SPAIN DRUG SAFETY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • ICON plc
  • Syneos Health, Inc.
  • Parexel International Corporation
  • Oracle Corporation
  • Veeva Systems Inc.
  • ArisGlobal LLC
  • EXL Service Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 17.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 45.84 Billion
Compound Annual Growth Rate21.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmacovigilance & Drug Safety Software Market - Global Forecast 2025-2030 - Product Image

Pharmacovigilance & Drug Safety Software Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Pharmacovigilance and Drug Safety Software Market Report by Functionality, Delivery Mode, End User, and Region 2025-2033 - Product Image

Pharmacovigilance and Drug Safety Software Market Report by Functionality, Delivery Mode, End User, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Pharmacovigilance Market - Global Forecast 2025-2030 - Product Image

Pharmacovigilance Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Post-Marketing Pharmacovigilance and Medical Information - Global Strategic Business Report - Product Image

Post-Marketing Pharmacovigilance and Medical Information - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.